
Mustafa Sahin MD
Neurologist-in-Chief and Chair of Neurology, Boston Children's Hospital; Professor of Neurology, Harvard Medical School
Join to View Full Profile
300 Longwood AvCLSB 14073Boston, MA 02115
Phone+1 617-919-6258
Fax+1 617-730-0284
Dr. Sahin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mustafa Sahin is a Child Neurologist in Boston, MA and is affiliated with Boston Children's Hospital. He received his medical degree from Yale University School of Medicine and has been in practice 22 years. He is experienced in tuberous sclerosis, autism spectrum disorders, and neurogenetics.
Education & Training
- Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Child Neurology, 1997 - 2000
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 1995 - 1997
- Yale School of MedicineClass of 1995
Certifications & Licensure
- MA State Medical License 2000 - 2025
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Awards, Honors, & Recognition
- Elected Member National Academy of Medicine, 2023
- The 2018 Philip R. Dodge Lecture Washington University, St Louis MO, 2018
- The Jacob’s Ladder Norman Saunders International Research Prize Hospital for Sick Children, Toronto, Canada, 2017
- Join now to see all
Clinical Trials
- Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) Start of enrollment: 2011 Jan 01
- A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures Start of enrollment: 2013 Apr 29
- Treatment of Rett Syndrome With Recombinant Human IGF-1 Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsQuantifying neurobehavioral profiles across neurodevelopmental genetic syndromes and idiopathic neurodevelopmental disorders.Thomas W Frazier, Robyn M Busch, Patricia Klaas, Katherine Lachlan, Eva Loth
Developmental Medicine and Child Neurology. 2025-05-01 - Aortic Root Dilation and Genotype Associations in Phelan-McDermid Syndrome.Jake Gluckman, Tess Levy, Kate Friedman, Francesca Garces, Rajna Filip-Dhima
American Journal of Medical Genetics. Part A. 2025-01-01 - Accumulated seizure burden predicts neurodevelopmental outcome at 36 months of age in patients with tuberous sclerosis complex.S Katie Z Ihnen, Samuel Alperin, Jamie K Capal, Alexander L Cohen, Jurriaan M Peters
Epilepsia. 2025-01-01
Press Mentions
- Disrupted Cell Skeletons May Explain Brain Wiring Changes in Autism-Linked ConditionJune 28th, 2021
- A Randomized Double-Blind Controlled Trial of Everolimus in Individuals with PTEN Mutations: Study Design and Statistical ConsiderationsFebruary 6th, 2021
- Earlier Treatment Could Help Reverse Autistic-like Behavior in Tuberous SclerosisOctober 10th, 2018
- Join now to see all
Grant Support
- Effects of 16p11.2 copy number variation on neuronal development and pathologyBOSTON CHILDREN'S HOSPITAL2023–2028
- Translational Post-doctoral Training in NeurodevelopmentBOSTON CHILDREN'S HOSPITAL2017–2027
- Translational Post-doctoral Training in NeurodevelopmentBOSTON CHILDREN'S HOSPITAL2017–2027
- Translational Post-doctoral Training in NeurodevelopmentBOSTON CHILDREN'S HOSPITAL2017–2027
- Translational Post-doctoral Training in NeurodevelopmentBOSTON CHILDREN'S HOSPITAL2017–2027
- Translational Post-doctoral Training in NeurodevelopmentBOSTON CHILDREN'S HOSPITAL2017–2027
- Translational Post-doctoral Training in NeurodevelopmentBOSTON CHILDREN'S HOSPITAL2017–2027
- Gene Therapy for Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)BOSTON CHILDREN'S HOSPITAL2024–2026
- Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research CenterBOSTON CHILDREN'S HOSPITAL2021–2026
- Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research CenterBOSTON CHILDREN'S HOSPITAL2021–2026
- Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research CenterBOSTON CHILDREN'S HOSPITAL2021–2026
- Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research CenterBOSTON CHILDREN'S HOSPITAL2021–2026
- Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research CenterBOSTON CHILDREN'S HOSPITAL2021–2026
- Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations - supplement #3BOSTON CHILDREN'S HOSPITAL2024–2025
- Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations - supplement #3BOSTON CHILDREN'S HOSPITAL2024–2025
- Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations - supplement #3BOSTON CHILDREN'S HOSPITAL2024–2025
- Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations - supplement #3BOSTON CHILDREN'S HOSPITAL2024–2025
- Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations - supplement #3BOSTON CHILDREN'S HOSPITAL2024–2025
- Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations - supplement #3BOSTON CHILDREN'S HOSPITAL2024–2025
- Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations - supplement #3BOSTON CHILDREN'S HOSPITAL2024–2025
Professional Memberships
- Member
- Child Neurology SocietyMember
- Society for NeuroscienceMember
- American Neurological AssociationMember
- INSARMember
External Links
- HMShttp://www.hms.harvard.edu/dms/bbs/fac/Sahin.php
- Lab Websitehttp://sahin-lab.org/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: